Journal of International Oncology››2014,Vol. 41››Issue (5): 321-323.doi:10.3760/cma.j.issn.1673-422X.2014.05.001
Ding Xiangli, Wang Haifeng, Yang Delin, et al
Received:
2014-01-06Revised:
2014-03-04Online:
2014-05-08Published:
2014-04-28Contact:
Yang Delin E-mail:ydelin@163.comDing Xiangli, Wang Haifeng, Yang Delin, et al. Roles of angiotensin Ⅱ receptors in tumor[J]. Journal of International Oncology, 2014, 41(5): 321-323.
[1] Doi C, Egashira N, Kawabata A, et al. Angiotensin Ⅱ type 2 receptor signaling significantly attenuates growth of murine pancreatic carcinoma grafts in syngeneic mice[J]. BMC cancer, 2010, 10(1):67. [2] PtasinskaWnuk D, Lawnicka H, Mucha S, et al. Angiotensins inhibit cell growth in GH3 lactosomatotroph pituitary tumor cell culture: a possible involvement of the p44/42 and p38 MAPK pathways[J]. Scient World J, 2012, 2012:189290. [3] Arafat HA, Gong Q, Chipitsyna G, et al. Antihypertensives as novel antineoplastics: angiotensinIconverting enzyme inhibitors and angiotensin Ⅱ type 1 receptor blockers in pancreatic ductal adenocarcinoma[J]. J Am Coll Surg, 2007, 204(5):996-1005. [4] Arrieta O, PinedaOlvera B, GuevaraSalazar P, et al. Expression of AT1 and AT2 angiotensin receptors in astrocytomas is associated with poor prognosis[J]. Br J Cancer, 2008, 99(1):160-166. [5] Shirotake S, Miyajima A, Kosaka T, et al. Angiotensin Ⅱ type 1 receptor expression and microvessel density in human bladder cancer[J]. Urology, 2011, 77(4):1009. [6] DolleyHitze T, Jouan F, Martin B, et al. Angiotensin2 receptors (AT1R and AT2R), new prognostic factors for renal clearcell carcinoma?[J]. Br J Cancer, 2010, 103(11):1698-1705. [7] Shirotake S, Miyajima A, Kosaka T, et al. Regulation of monocyte chemoattractant protein1 through angiotensin Ⅱ type 1 receptor in prostate cancer[J]. Am J Pathol, 2012, 180(3):1008-1016. [8] Rcken C, Rhl FW, Diebler E, et al. The angiotensin Ⅱ/angiotensin Ⅱ receptor system correlates with nodal spread in intestinal type gastric cancer[J]. Cancer Epidemiol Biomarkers Prev, 2007, 16(6):1206-1212. [9] CarlMcGrath S, Ebert MP, Lendeckel U, et al. Expression of the local angiotensin Ⅱ system in gastric cancer may facilitate lymphatic invasion and nodal spread[J]. Cancer Biol Ther, 2007, 6(8):1218-1226. [10] Munn LL. Dynamics of tissue topology during cancer invasion and metastasis[J]. Phys Biol, 2013, 10(6):65003. [11] Ino K, Shibata K, Yamamoto E, et al. Role of the reninangiotensin system in gynecologic cancers[J]. Curr Cancer Drug Tar, 2011, 11(4):405-411. [12] Buharalioglu CK, Song CY, Yaghini FA, et al. Angiotensin Ⅱ induced process of angiogenesis is mediated by spleen tyrosine kinase via VEGF receptor1 phosphorylation[J]. Am J Physiol Heart Circ Physiol, 2011, 301(3):H1043-1055. [13] Imai N, Hashimoto T, Kihara M, et al. Roles for host and tumor angiotensin Ⅱ type 1 receptor in tumor growth and tumorassociated angiogenesis[J]. Lab Invest, 2007, 87(2):189-198. [14] Lau ST, Leung PS. Role of the RAS in pancreatic cancer[J]. Curr Cancer Drug Targets, 2011, 11(4):412-420. [15] 王亮, 何裕隆, 张常华, 等. 血管紧张素转换酶抑制剂和血管紧张素Ⅱ受体拮抗剂抑制胃癌淋巴管生成的实验研究[J]. 消化肿瘤杂志(电子版), 2008, 1(1)34-39. [16] Pickel L, Matsuzuka T, Doi C, et al. Overexpression of angiotensinⅡ type 2 receptor gene induces cell death in lung adenocarcinoma cells[J]. Cancer Biol Ther, 2010, 9(4):277-285. [17] Louis SN, Chow L, Rezmann L, et al. Expression and function of ATIP/MTUS1 in human prostate cancer cell lines[J]. Prostate, 2010, 70(14):1563-1574. [18] Clere N, Corre I, Faure S, et al. Deficiency or blockade of angiotensin Ⅱ type 2 receptor delays tumorigenesis by inhibiting malignant cell proliferation and angiogenesis[J]. Int J Cancer, 2010, 127(10):2279-2291. |
[1] | Liu Na, Kou Jieli, Yang Feng, Liu Taotao, Li Danping, Han Junrui, Yang Lizhou.Clinical value of serum miR-106b-5p and miR-760 combined with low-dose spiral CT in the diagnosis of early lung cancer[J]. Journal of International Oncology, 2024, 51(6): 321-325. |
[2] | Yang Mi, Bie Jun, Zhang Jiayong, Deng Jiaxiu, Tang Zuge, Lu Jun.Analysis of the efficacy and prognosis of neoadjuvant therapy for locally advanced resectable esophageal cancer[J]. Journal of International Oncology, 2024, 51(6): 332-337. |
[3] | Yuan Jian, Huang Yanhua.Diagnostic value of Hp-IgG antibody combined with serum DKK1 and sB7-H3 in early gastric cancer[J]. Journal of International Oncology, 2024, 51(6): 338-343. |
[4] | Chen Hongjian, Zhang Suqing.Study on the relationship between serum miR-24-3p, H2AFX and clinical pathological features and postoperative recurrence in liver cancer patients[J]. Journal of International Oncology, 2024, 51(6): 344-349. |
[5] | Guo Zehao, Zhang Junwang.Role of PFDN and its subunits in tumorigenesis and tumor development[J]. Journal of International Oncology, 2024, 51(6): 350-353. |
[6] | Zhang Baihong, Yue Hongyun.Advances in anti-tumor drugs with new mechanisms of action[J]. Journal of International Oncology, 2024, 51(6): 354-358. |
[7] | Xu Fenglin, Wu Gang.Research progress of EBV in tumor immune microenvironment and immunotherapy of nasopharyngeal carcinoma[J]. Journal of International Oncology, 2024, 51(6): 359-363. |
[8] | Wang Ying, Liu Nan, Guo Bing.Advances of antibody-drug conjugate in the therapy of metastatic breast cancer[J]. Journal of International Oncology, 2024, 51(6): 364-369. |
[9] | Zhang Rui, Chu Yanliu.Research progress of colorectal cancer risk assessment models based on FIT and gut microbiota[J]. Journal of International Oncology, 2024, 51(6): 370-375. |
[10] | Gao Fan, Wang Ping, Du Chao, Chu Yanliu.Research progress on intestinal flora and non-surgical treatment of the colorectal cancer[J]. Journal of International Oncology, 2024, 51(6): 376-381. |
[11] | Liu Jing, Liu Qin, Huang Mei.Prognostic model construction of lung infection in patients with chemoradiotherapy for esophageal cancer based on SMOTE algorithm[J]. Journal of International Oncology, 2024, 51(5): 267-273. |
[12] | Yang Lin, Lu Ning, Wen Hua, Zhang Mingxin, Zhu Lin.Study on the clinical relationship between inflammatory burden index and gastric cancer[J]. Journal of International Oncology, 2024, 51(5): 274-279. |
[13] | Wang Junyi, Hong Kaibin, Ji Rongjia, Chen Dachao.Effect of cancer nodules on liver metastases after radical resection of colorectal cancer[J]. Journal of International Oncology, 2024, 51(5): 280-285. |
[14] | Zhang Ningning, Yang Zhe, Tan Limei, Li Zhenning, Wang Di, Wei Yongzhi.Diagnostic value of cervical cell DNA ploidy analysis combined with B7-H4 and PKCδ for cervical cancer[J]. Journal of International Oncology, 2024, 51(5): 286-291. |
[15] | Fu Yi, Ma Chenying, Zhang Lu, Zhou Juying.Research progress of habitat analysis in radiomics of malignant tumors[J]. Journal of International Oncology, 2024, 51(5): 292-297. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||